Loading...

APC anti-mouse CD3 Antibody

Pricing & Availability
Clone
17A2 (See other available formats)
Regulatory Status
RUO
Other Names
T cell antigen receptor complex, T3
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
17A2_APC_073012
C57BL/6 mouse splenocytes were stained with CD3 (clone 17A2) APC (filled histogram) or rat IgG2b, κ isotype control (open histogram).
  • 17A2_APC_073012
    C57BL/6 mouse splenocytes were stained with CD3 (clone 17A2) APC (filled histogram) or rat IgG2b, κ isotype control (open histogram).
See APC spectral data
Cat # Size Price Quantity Check Availability Save
100235 25 µg $33
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100236 100 µg $77
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex

Product Details
Technical data sheet

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References

(PubMed link indicates BioLegend citation)
  1. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  2. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Liu Y, et al. 2017. Oncogene. 10.1038/onc.2017.209. PubMed
  2. Agelidis A, et al. 2017. Cell Rep. 10.1016/j.celrep.2017.06.041. PubMed
  3. Zhang J, et al. 2018. Nature. 553:91. PubMed
  4. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  5. Yamamoto R et al. 2018. Cell stem cell. 22(4):600-607 . PubMed
  6. Xi‐Zhi J Guo et al. 2018. Immunity. 49(3):531-544 . PubMed
  7. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  8. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  9. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  10. Zhang W, et al. 2019. Oncol Lett. 17:815. PubMed
  11. Haikala HM, et al. 2019. Nat Commun. 10:620. PubMed
  12. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  13. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  14. Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed
  15. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  16. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  17. Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed
  18. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  19. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  20. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  21. Swidergall M, et al. 2019. Cell Rep. 28:423. PubMed
  22. Thomas S, et al. 2019. J Immunother Cancer. 7:214. PubMed
  23. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  24. Liu J, et al. 2019. Immunity. 50:600. PubMed
  25. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  26. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  27. Hiramoto T, et al. 2018. Mol Ther. 26:1255. PubMed
  28. Sartorius R, et al. 2018. Front Immunol. 1.413888889. PubMed
  29. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  30. Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed
  31. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  32. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  33. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  34. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  35. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  36. Yoshimi A, et al. 2019. Nature. 574:273. PubMed
  37. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  38. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  39. Siddique SM, et al. 2019. Sci Rep. 9:13977. PubMed
  40. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  41. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  42. Lightman SM, et al. 2020. Cell Reports. 1.086805556. PubMed
  43. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  44. Utz B, et al. 2020. Sci Rep. 10:18733. PubMed
  45. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  46. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  47. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  48. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
  49. Gardenier J, et al. 2017. Nat Commun. 8:14345. PubMed
  50. Wang X, et al. 2020. Nat Commun. 4.505555556. PubMed
  51. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  52. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  53. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  54. Gruber T, et al. 2020. JCI Insight. 5:00. PubMed
  55. Johnson DC, et al. 2020. Cell Death Dis. 0.894444444. PubMed
  56. Utley A, et al. 2020. Cell Rep. 31:107815. PubMed
  57. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  58. Court AC, et al. 2020. EMBO Rep. 21:e48052. PubMed
  59. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  60. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  61. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  62. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  63. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  64. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  65. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  66. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  67. Lazarian G, et al. 2021. Cancer Cell. 39(3):380-393.e8. PubMed
  68. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  69. Magod P, et al. 2021. Cell Reports. 36(5):109480. PubMed
  70. Wang Y, et al. 2021. Cell Reports. 36(6):109516. PubMed
  71. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  72. Sano T, et al. 2021. Cell Reports. 36:109608. PubMed
  73. Liu P, et al. 2020. Mol Cell. 748:77. PubMed
  74. Liu Y, et al. 2020. Oncol Lett. 2369:20. PubMed
  75. Adnan-Awad S, et al. 2020. Leukemia. . PubMed
  76. Forte E, et al. 2020. J Cell Mol Med. . PubMed
  77. Calabrese DR, et al. 2020. J Clin Invest. . PubMed
  78. Zeng A, et al. 2020. Oncol Rep. . PubMed
  79. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  80. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  81. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
  82. Kim S, et al. 2020. Autophagy. :1. PubMed
  83. Das A, et al. 2020. J Bone Miner Res. 36:199. PubMed
  84. Han F, et al. 2020. Invest Ophthalmol Vis Sci. 61:24. PubMed
  85. Lake CM, et al. 2021. Cell Death Dis. 12:400. PubMed
  86. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  87. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  88. Fu X, et al. 2020. J Immunol. 205:2066. PubMed
  89. Kujur W, et al. 2020. PLoS Pathog. 16:e1009132. PubMed
  90. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  91. Fujino T, et al. 2021. Nat Commun. 12:1826. PubMed
  92. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  93. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  94. Baram T, et al. 2021. Cells. 10:. PubMed
  95. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  96. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  97. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  98. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  99. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  100. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  101. Wu G, et al. 2020. Br J Pharmacol. 177:5063. PubMed
  102. Li X, et al. 2020. Mol Ther. 28:2430. PubMed
  103. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  104. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  105. Rivas MA, et al. 2021. Nat Immunol. 22:240. PubMed
  106. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  107. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  108. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
  109. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  110. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  111. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  112. Almutairi F, et al. 2021. Front Immunol. 12:772288. PubMed
  113. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  114. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  115. Mastandrea I, et al. 2022. STAR Protoc. 3:101106. PubMed
  116. Yoshida S, et al. 2022. PLoS One. 17:e0264317. PubMed
  117. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  118. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  119. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  120. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  121. Li H, et al. 2022. iScience. 25:104481. PubMed
  122. Kelley WJ, et al. 2022. JCI Insight. 7: . PubMed
  123. Kremenovic M, et al. 2022. J Immunother Cancer. 10:. PubMed
  124. Francian A, et al. 2021. J Drug Target. 29:754. PubMed
  125. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  126. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  127. Pessoa Rodrigues C, et al. 2021. Sci Adv. 7:. PubMed
  128. Wang Y, et al. 2021. Front Microbiol. 12:701566. PubMed
  129. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  130. Arora S, et al. 2021. Med (N Y). 2:938. PubMed
  131. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  132. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  133. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  134. van Elsas MJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  135. Martinez-Turtos A, et al. 2022. Oncoimmunology. 11:2116844. PubMed
  136. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  137. Tomala J, et al. 2020. Methods Mol Biol. 2111:101. PubMed
  138. Tang D, et al. 2020. Br J Haematol. 191:906. PubMed
  139. Olivo Pimentel V, et al. 2021. J Immunother Cancer. 9:. PubMed
  140. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  141. Olson CA, et al. 2021. Cell Host Microbe. 29:1378. PubMed
  142. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  143. Xiong W, et al. 2022. Adv Sci (Weinh). 9:e2103029. PubMed
  144. Zhang X, et al. 2022. Pharmaceutics. 14:. PubMed
  145. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  146. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  147. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  148. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  149. Wen M, et al. 2022. JCI Insight. Online ahead of print. PubMed
  150. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  151. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  152. Ren HZ, et al. 2022. J Clin Transl Hepatol. 10:1138. PubMed
  153. Stirling ER, et al. 2022. J Immunother Cancer. 10:. PubMed
  154. Pascual-Pasto G, et al. 2022. J Immunother Cancer. 10:. PubMed
  155. Hilfenhaus G, et al. 2021. Cancer Res. 81:619. PubMed
  156. Denny L, et al. 2021. Clin Transl Immunology. 10:e1234. PubMed
  157. Ramos SA, et al. 2022. J Allergy Clin Immunol. 149:767. PubMed
  158. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  159. Sugiura A, et al. 2022. Immunity. 55:65. PubMed
  160. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  161. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  162. Qi X, et al. 2022. FASEB J. 36:e22250. PubMed
  163. van Dierendonck XAMH, et al. 2022. Proc Natl Acad Sci U S A. 119:e2114739119. PubMed
  164. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  165. Tu J, et al. 2022. Cancer Sci. 113:2496. PubMed
  166. Dolfi B, et al. 2022. Cell Rep. 39:110949. PubMed
  167. Du M, et al. 2022. Cancer Sci. 113:2974. PubMed
  168. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  169. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  170. Zhu J, et al. 2022. Research (Wash D C). 2022:9816272. PubMed
  171. Zhang Z, et al. 2022. Integr Cancer Ther. 21:15347354221138534. PubMed
  172. Miró L, et al. 2022. Cancers (Basel). 14: . PubMed
  173. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  174. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  175. Lin J, et al. 2023. Nat Commun. 14:224. PubMed
  176. Kang J, et al. 2023. JCI Insight. 8: . PubMed
  177. Chen Y, et al. 2023. Stem Cells Int. 2023:7482546. PubMed
  178. Li X, et al. 2022. Cell. 185:1709. PubMed
  179. Bergmann CA, et al. 2022. Cells. 11:. PubMed
  180. Akhtar MN, et al. 2022. MBio. 13:e0330921. PubMed
  181. Balakrishnan PB, et al. 2022. Nano Res. 15:2300. PubMed
  182. Shi X, et al. 2022. Proc Natl Acad Sci U S A. 119:e2208506119. PubMed
  183. Ho HM, et al. 2022. Pharmaceutics. 14:. PubMed
  184. Sparbier CE, et al. 2023. Nat Cell Biol. 25:258. PubMed
  185. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  186. Wang X, et al. 2023. J Immunother Cancer. 11:. PubMed
  187. Liu N, et al. 2023. Cell Death Dis. 14:170. PubMed
  188. Gupta T, et al. 2023. Front Immunol. 14:1044703. PubMed
  189. Mabire M, et al. 2023. Nat Commun. 14:1830. PubMed
  190. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  191. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  192. Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed
  193. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  194. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  195. Cansever D, et al. 2023. Nat Immunol. . PubMed
RRID
AB_2561455 (BioLegend Cat. No. 100235)
AB_2561456 (BioLegend Cat. No. 100236)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org
Go To Top Version: 1    Revision Date: 11/30/2012

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account